CDC and Pfizer are developing genetically modified H5 avian influenza constructs using the same mRNA platform as covid-19
Researchers from the U.S. Centers for Disease Control and Prevention (CDC) and Pfizer Inc. have developed new, genetically engineered H5 avian influenza gene constructs, including a codon-optimized hemagglutinin (HA) gene with a synthetically modified cleavage site, as documented in a report published in Nature on November 27.…
Read More...
Read More...